Tetje C. Van Der Sluis
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Inhibiting the NADase CD38 improves cytomegalovirus-specific CD8+ T cell functionality and metabolism.
Journal: The Journal of clinical investigation
Published: January 18, 2024
Delayed vaccine-induced CD8+ T cell expansion by topoisomerase I inhibition mediates enhanced CD70-dependent tumor eradication.
Journal: Journal for immunotherapy of cancer
Published: November 05, 2023
CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours.
Journal: Nature
Published: June 16, 2022
OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum.
Journal: Cell reports. Medicine
Published: February 10, 2022
A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection.
Journal: Nature communications
Published: December 17, 2021
Tumor cell intrinsic Toll-like receptor 4 signaling promotes melanoma progression and metastatic dissemination.
Journal: International journal of cancer
Published: March 06, 2021
Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: August 06, 2020
Interleukin-6-mediated resistance to immunotherapy is linked to impaired myeloid cell function.
Journal: International journal of cancer
Published: April 29, 2020
Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradication.
Journal: Journal for immunotherapy of cancer
Published: February 23, 2018
Inhibition of 14q32 microRNA miR-495 reduces lesion formation, intimal hyperplasia and plasma cholesterol levels in experimental restenosis.
Journal: Atherosclerosis
Published: November 21, 2016
Last Updated: 09/26/2026